MIT engineers have developed an implantable device for Type 1 diabetes treatment. The device contains insulin-producing cells and self-generates oxygen by splitting bodily water vapor. Promising results in diabetic mice show stabilized glucose levels. This advancement could eliminate daily insulin injections, offering a groundbreaking solution for diabetes management.

  • @Cocodapuf
    link
    21 year ago

    So many questions…

    Is the “Oxygen factory” component worn externally?

    How exactly does it separate the Oxygen from vapor? What do they mean by “vapor”, does that mean the implant needs access to the respiratory system somehow?